Viewing Study NCT00456794


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2025-12-28 @ 12:04 AM
Study NCT ID: NCT00456794
Status: COMPLETED
Last Update Posted: 2024-04-25
First Post: 2007-04-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: 12-Week, Double-Blind, Placebo-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa
Sponsor: Kyowa Kirin, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2002-03
Start Date Type: None
Primary Completion Date: 2003-10
Primary Completion Date Type: ACTUAL
Completion Date: 2003-10
Completion Date Type: ACTUAL
First Submit Date: 2007-04-03
First Submit QC Date: None
Study First Post Date: 2007-04-05
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-04-23
Last Update Post Date: 2024-04-25
Last Update Post Date Type: ACTUAL